Scotia Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $596K | Buy |
1,136
+6
| +0.5% | +$3.15K | ﹤0.01% | 602 |
|
|
2025
Q1 | $717K | Buy |
+1,130
| New | +$717K | ﹤0.01% | 562 |
|
|
2024
Q4 | – | Sell |
-1,077
| Closed | -$1.13M | – | 907 |
|
|
2024
Q3 | $1.13M | Buy |
1,077
+630
| +141% | +$662K | 0.01% | 493 |
|
|
2024
Q2 | $470K | Buy |
447
+14
| +3% | +$14.7K | ﹤0.01% | 613 |
|
|
2024
Q1 | $417K | Buy |
433
+22
| +5% | +$21.2K | ﹤0.01% | 628 |
|
|
2023
Q4 | $361K | Buy |
411
+117
| +40% | +$103K | ﹤0.01% | 628 |
|
|
2023
Q3 | $242K | Buy |
+294
| New | +$242K | ﹤0.01% | 683 |
|
|
2023
Q1 | – | Sell |
-383
| Closed | -$276K | – | 816 |
|
|
2022
Q4 | $276K | Sell |
383
-2
| -0.5% | -$1.44K | ﹤0.01% | 655 |
|
|
2022
Q3 | $265K | Sell |
385
-38
| -9% | -$26.2K | ﹤0.01% | 652 |
|
|
2022
Q2 | $250K | Buy |
423
+84
| +25% | +$49.6K | ﹤0.01% | 688 |
|
|
2022
Q1 | $237K | Sell |
339
-3,997
| -92% | -$2.79M | ﹤0.01% | 774 |
|
|
2021
Q4 | $2.74M | Buy |
4,336
+78
| +2% | +$49.3K | 0.02% | 350 |
|
|
2021
Q3 | $2.58M | Sell |
4,258
-3,175
| -43% | -$1.92M | 0.02% | 345 |
|
|
2021
Q2 | $4.15M | Sell |
7,433
-2,563
| -26% | -$1.43M | 0.03% | 266 |
|
|
2021
Q1 | $4.73M | Buy |
9,996
+42
| +0.4% | +$19.9K | 0.04% | 233 |
|
|
2020
Q4 | $4.81M | Buy |
9,954
+1,174
| +13% | +$567K | 0.04% | 209 |
|
|
2020
Q3 | $4.92M | Buy |
8,780
+924
| +12% | +$517K | 0.05% | 181 |
|
|
2020
Q2 | $4.9M | Buy |
7,856
+1,419
| +22% | +$885K | 0.07% | 153 |
|
|
2020
Q1 | $3.14M | Buy |
6,437
+5,879
| +1,054% | +$2.87M | 0.04% | 196 |
|
|
2019
Q4 | $210K | Buy |
+558
| New | +$210K | ﹤0.01% | 689 |
|
|
2019
Q3 | – | Sell |
-961
| Closed | -$301K | – | 772 |
|
|
2019
Q2 | $301K | Sell |
961
-395
| -29% | -$124K | ﹤0.01% | 603 |
|
|
2019
Q1 | $557K | Buy |
1,356
+542
| +67% | +$223K | 0.01% | 482 |
|
|
2018
Q4 | $304K | Buy |
814
+57
| +8% | +$21.3K | ﹤0.01% | 543 |
|
|
2018
Q3 | $306K | Sell |
757
-16
| -2% | -$6.47K | ﹤0.01% | 606 |
|
|
2018
Q2 | $262K | Buy |
773
+8
| +1% | +$2.71K | ﹤0.01% | 594 |
|
|
2018
Q1 | $263K | Buy |
+765
| New | +$263K | ﹤0.01% | 619 |
|